ONOV - BioNovelus Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0850
-0.0049 (-5.45%)
At close: 3:06PM EST
Stock chart is not supported by your current browser
Previous Close0.0899
Open0.0900
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0790 - 0.0900
52 Week Range0.0040 - 0.1489
Volume175,797
Avg. Volume105,728
Market Cap18,646
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateNov 11, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    BioNovelus, Inc. Announces Austin Branch to Join Advisory Board

    POTOMAC, Md., Jan. 21, 2020 -- BioNovelus, Inc. (OTC: ONOV) announces that Austin Branch has joined the Company’s Advisory Board.  BioNovelus’ Advisory Board seats individual,.

  • GlobeNewswire

    BioNovelus, Inc. Announces Additions to its Finance Team

    POTOMAC, Md., Dec. 17, 2019 -- BioNovelus, Inc. (OTC: ONOV) announces two additions to its finance team. BioNovelus hired KBL, LLP of New York, NY (www.kbl.com) to serve as.

  • GlobeNewswire

    BioNovelus, Inc. Announces Trey Blalock to Join Advisory Board

    BioNovelus, Inc. (ONOV) announces that Trey Blalock joined the Company’s Advisory Board. Trey Blalock is currently the Chief Development Officer and Chief Legal Officer for Health Care Navigator and its affiliates.

  • GlobeNewswire

    BioNovelus, Inc. Announces the Closing of its Acquisition of Corvus Consulting, LLC

    POTOMAC, Md., Nov. 25, 2019 -- BioNovelus, Inc. (OTC: ONOV) announces the closing of its previously announced acquisition of Corvus Consulting, LLC.  BioNovelus, a.

  • GlobeNewswire

    BioNovelus Announces Filing of Third Quarter 2019 Financial Report

    BioNovelus, Inc. (ONOV) announces it has submitted its 2019 3Q report on www.otcmarkets.com. Other than payables in the ordinary course, the only remaining third-party debt as of November 11, 2019 is an $11,000 promissory note due in June 2020. “The continued improvement in the financial condition of the company has been one of the key areas of focus since we acquired control of the Company in June of this year.

  • GlobeNewswire

    BioNovelus, Inc. Announces Patricia Frost to Join Advisory Board

    BioNovelus, Inc. (ONOV) announces Patricia Frost has joined the Company’s Advisory Board.  BioNovelus’ Advisory Board seats individual entrepreneurs and senior cyber security / information technology (IT) executives with business, government and technical expertise useful for assisting in identifying, integrating and growing acquired companies. Patricia Frost is currently a Director of Cyber for Partners in Performance, America where she heads the management consulting group responsible for reducing operational risk in the cyber area.  She is also a Senior Advisor in the Thayer Leader Development Group, the mission of which is to help C-level teams take charge of their own leadership, deliberately shape their organization's culture and creatively tackle their business challenges.  Patricia is also President of Patricia Frost & Associates, LLC, an Executive management consulting firm that is focused on leadership, government relations, strategic communications and delivering measurable results.

  • Newsfile

    BioNovelus, Inc. Discusses Their New Growth Strategy with The Stock Day Podcast

    Phoenix, Arizona--(Newsfile Corp. - October 15, 2019) - The Stock Day Podcast welcomed BioNovelus, Inc. (OTC Pink: ONOV) ("the Company"), a company with a mission to acquire cybersecurity / IT and related companies after being acquired by a new management team. President and CEO of the Company, Mark Fuller, joined Stock Day host Everett Jolly. Jolly began the interview by asking, "What have been your accomplishments since taking control of the company?". Fuller explained ...

  • GlobeNewswire

    BioNovelus, Inc. Announces Letter of Intent to Purchase Corvus Consulting, LLC

    Corvus, a leading provider of scientific, engineering, technical, operational support, and training services to the federal government and commercial clients, focuses on cyberspace operations, electronic warfare, information operations, intelligence, and joint/electromagnetic spectrum operations.   The company’s capabilities include high-level policy development and congressional liaison to requirements analysis, and provides DOTMLPF-p solutions to development assistance and design services for hardware and software systems fulfilling the mission needs of the U.S. Department of Defense and U.S. Intelligence Communities. Corvus has trailing twelve month revenue in excess of $10 million and is profitable.

  • GlobeNewswire

    BioNovelus, Inc. Announces Bob Eisiminger to Join Advisory Board

    BioNovelus, Inc. (ONOV) announces Bob Eisiminger has joined the Company’s newly created Advisory Board.  BioNovelus’ Advisory Board seats individual entrepreneurs and senior Information Technology (IT) executives with business and technical expertise useful for assisting in identifying, integrating and growing acquired companies. Bob Eisiminger most recently served as the Chief Executive Officer of Knight Point Systems (KPS) from its founding to its sale to Perspecta for $250 million in July 2019. With over 30 years of professional experience, Bob held a variety of leadership positions in several industries.  Prior to forming KPS, Bob’s healthcare industry experience in various sales management and leadership development positions earned him top sales honors.

  • GlobeNewswire

    BioNovelus Announces Removal of Yield Sign

    BioNovelus, Inc. (ONOV) announces it has submitted all necessary documentation, including its 2019 2Q report, to qualify as a “Pink Current” company on the OTC Markets. “We are pleased to take this next step to provide investors with more information about our Company to help them better analyze the value and potential of our company,” said Mark Fuller, President, and CEO of BioNovelus. This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.

  • GlobeNewswire

    BioNovelus Announces Removal of Stop Sign

    BioNovelus, Inc. (ONOV) announces it has submitted all necessary documentation to qualify as a “Limited Information” company on the OTC Markets. Management plans to file ONOV’s Q2 report before August 14, 2019.

  • GlobeNewswire

    BioNovelus, Inc. Announces Ian Gerrard as Head of Corporate Finance and Accounting

    Mr. Gerrard has led several finance organizations in numerous public and private companies during his distinguished business career.  He has worked in a number of public and private companies where he has been the CFO and has been responsible for M&A activities, capital markets, and valuations of target companies.  Mr. Gerrard’s career includes public accounting, MCI, Sprint International/Global One and CFO of COMSAT International where he oversaw expansion of the company into new international markets and the eventual sale to a global telecoms company  He holds a B.Sc.